Mentions
Extended reach
Total likes
Video views
AI synopsis
The discussions include specific references to the article's conclusions, such as acknowledgment of the benefits of using GPT-4 for patient communication, while also highlighting concerns about data privacy and the need for careful implementation. Phrases like 'must read paper' and 'potential to help healthcare providers' indicate a tone of excitement and recognition of the transformative role AI could play in medicine, reinforcing the overall positive sentiment.
The majority of discussions reflect a supportive view towards the findings and recommendations in the article regarding the use of GPT-4 in medicine.
There is a clear enthusiasm for exploring the implications and potential applications of AI in healthcare, as evidenced by numerous mentions of the article.
Many discussions include critical questions and elaborations on the article's content, showing that participants are thinking deeply about the subject.
Participants perceive that this research could significantly influence medical practices and the integration of AI technologies.
This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.co/K53iWddhUs
Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://t.co/waBaFAWMwB 2) @AllenInstitute Talk: https://t.co/KNCruSbEgv 3) Book: https://t.co/HG4K2PXLR3 Non-MSFT: our @UCSF grand rounds: https://t.co/QKRbMi5mFV
NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #AIinMedicine https://t.co/E804sTUJop
3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.co/VFt5iqljYA
｢AI医療チャットボットの可能性とリスク｣ (NEJM) 1️⃣ 医療文書作成、診断支援、研究資料要約など、多岐にわたる医療分野での活用 2️⃣ GPT-4はUSMLEの問題に対して90%以上の正答率 3️⃣ 注意点: 誤った情報を伝えることがあるため、チェックが必要 #AI #GPT4 #HealthTech https://t.co/6az5lXmCxj https://t.co/5TVQEFjBsk
In this episode, we examine the final results of the MASTERDAPT trial, which shows abbreviated antiplatelet therapy is noninferior to standard therapy for high-bleeding-risk patients. We also discuss implications for AI…
This video explores the use of generative AI tools like ChatGPT and Gemini in healthcare. It discusses benefits such as improved patient communication and decision-making support, alongside the risks, limitations, and…
This video explores the fascinating concept of quantum entanglement, where particles become interconnected across distances. Discover how this phenomenon challenges our understanding of physics and its implications for…
https://t.co/Dyr83aaBw5
RT @IDSAMedEdCOP: How should we use AI chatbots in medicine? Check out this @NEJM article on the benefits, limits, and risks of GPT-4 as a…
Son olarakta kaynağım: https://t.co/90MINVDsTI
ing in clinical medicine, 2023. N. Engl. J. Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine, N Engl J. Med 2023; 388: 1233-9. I, Tonya have been used for others. Those involved have broken every law. I even believe that they used Harvard and Beth Frates.
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
Dalla rivista free full-text creata da poco dal New England Journal of Medicine e dedicata interamente alle applicazioni dell’intelligenza artificiale in medicina. https://t.co/wFSOYBJkEG
@alan_karthi @GoogleAI @GoogleDeepMind @GoogleHealth @vivnat @taotu831 @HardyShakerman @apalepu13 @KhaledSaab11 @brennali_ @AziziShekoofeh @thekaransinghal @RyutaroTanno @JanFreyberg @weballergy @Mysiak @ymatias @greg_corrado Thanks for the detailed explanation. Could you comment on if you noticed the limitations presented in this paper below. This work was testing a general purpose model in healthcare so quite different from your domain adapted model https://t.co/d8LU8pMQYn
@iScienceLuvr @GoogleDeepMind @vivnat @alan_karthi I wonder how this compares to the findings in the paper below using GPT4, I'd think adapting domains by training on medical data should make a big difference. Thoughts? https://t.co/d8LU8pMQYn
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/OLJ3PwymzC
Buna “halüsinasyon” da deniyor. Konu hakkında detaylı bilgi sahibi olmak için aşağıdaki linki ziyaret edebilirsiniz. https://t.co/3PHtcHWRmZ
RT @__stock_: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/mCvAlWqxXC
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @imedverse: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine @NEJM #GPT4 #MedEd #MedTwitter https://t.co/83gAa3EGBp…
RT @imedverse: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine @NEJM #GPT4 #MedEd #MedTwitter https://t.co/83gAa3EGBp…
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine @NEJM #GPT4 #MedEd #MedTwitter https://t.co/83gAa3EGBp https://t.co/s6o1qgsROZ
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #AIinMedicine https://t.co/E804sTUJop
RT @NEJM: This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #Artif…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
Ventajas, límites y riesgos de GPT-4 como chatbot de inteligencia artificial para medicina (N Engl J Med. 2023 Mar 30;388(13):1233-1239. doi: 10.1056/NEJMsr2214184). https://t.co/2BcvDgqIbT
RT @alberthenriquez: @AntelmPujol Es claro que los motores de IA aún tienen mucho margen de error, derivado del sesgo en la selección de co…
RT @alberthenriquez: @AntelmPujol Es claro que los motores de IA aún tienen mucho margen de error, derivado del sesgo en la selección de co…
@AntelmPujol Es claro que los motores de IA aún tienen mucho margen de error, derivado del sesgo en la selección de contenidos de datos... será algo a resolver en el futuro pero se convertirán en una herramienta más para el ejercicio médico y la vida misma. https://t.co/yUD2WwvgvG
RT @NEJM: This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #Artif…
RT @airesearchtools: Do you know which is the most cited New England Journal of Medicine article of 2023? Need clues? Lee, P., Bubeck, S.…
RT @airesearchtools: Do you know which is the most cited New England Journal of Medicine article of 2023? Need clues? Lee, P., Bubeck, S.…
Do you know which is the most cited New England Journal of Medicine article of 2023? Need clues? Lee, P., Bubeck, S., & Petro, J. (2023). Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. The New England Journal of Medicine, 388(13), 1233-1239. https://t.co/mXvW9SvSIh
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
RT @NEJM: This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW…
This week’s most cited articles: 1. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.co/K53iWddhUs
RT @NEJM: This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #Artif…
RT @NEJM: This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #Artif…
RT @NEJM: This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #Artif…
RT @NEJM: This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #Artif…
This week’s most cited article: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.co/gw3IhQ2PpM
RT @TASUKU2023: こちらもとてもまとまっていて面白いです https://t.co/lIjQFHE2xj
こちらもとてもまとまっていて面白いです https://t.co/lIjQFHE2xj
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
RT @NEJM: 3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.c…
3. Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/Krl435ZltW #ArtificialIntelligence https://t.co/VFt5iqljYA
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM. GPT-4作为医学AI聊天机器人的优势、局限和风险 https://t.co/FHLvxlUYkk
RT @JJRiosBlanco: “If used carefully and with an appropriate degree of caution, these evolving tools have the potential to help health care…
ChatGPTを研究手法として用いる際の結果の再現性について警鐘を鳴らし、適切な報告方法について提案しています(https://t.co/WT6yjG7RJZ)。 ◾️Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine (N Engl J Med 2023; 388:2399-2400) https://t.co/V1HCBgHG7Y
RT @FarhadShokrane: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/UlhGpklmhu
RT @dariomics: @Abraham_RMI Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine CC @Abraham_RMI https://t.co/gwiLEVai7n htt…
RT @dariomics: @Abraham_RMI Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine CC @Abraham_RMI https://t.co/gwiLEVai7n htt…
@Abraham_RMI Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine CC @Abraham_RMI https://t.co/gwiLEVai7n https://t.co/7RvWevD0GC
RT @tweetderma: Son reproducibles los resultados de la IA en medicina? Responde siempre igual? Benefits, Limits, and Risks of GPT-4 as an…
RT @hernangraffe: https://t.co/ztaKdxxbgh
Son reproducibles los resultados de la IA en medicina? Responde siempre igual? Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/su4GymQtc7
RT @TruLensML: "Although we have found #GPT4 to be extremely powerful, it also has important limitations... we believe that the question re…
"Although we have found #GPT4 to be extremely powerful, it also has important limitations... we believe that the question regarding what is... acceptable performance of general AI remains to be answered." https://t.co/cVv4ZcTxhw @peteratmsr @sebastienbubeck Joseph Petro @NEJM
RT @FarhadShokrane: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/UlhGpklmhu
https://t.co/ztaKdxxbgh
RT @FarhadShokrane: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/UlhGpklmhu
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/UlhGpklmhu
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
"Benefits, Limits, and Risks of GPT-4 as an #AI #Chatbot for Medicine" | NEJM via @julianig #GPT4 https://t.co/Oz1K7NpQss
RT @AIMedHQ: Read about an AI system from OpenAI called generative pre-trained transformer 4 that can be adopted for medicine>https://t.co/…
Read about an AI system from OpenAI called generative pre-trained transformer 4 that can be adopted for medicine>https://t.co/bBJ3CC15K5
#ChatGPT, MD? Read more about this @NEJM special report on the “Benefits, Limits, and Risks of GPT-4 as an #AI Chatbot for Medicine.” https://t.co/SNUEPzbGfy
RT @hernangraffe: https://t.co/ztaKdxxbgh
RT @peteratmsr: Our new article in @NEJM introduces clinical practitioners to the potential benefits, limits, and risks of #GPT4 AI in medi…
https://t.co/ztaKdxxbgh
RT @hernangraffe: https://t.co/ztaKdxxbgh
https://t.co/ztaKdxxbgh
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
مقالة جميلة تهم الكثير من العاملين بالقطاع الطبي، قرأتها واجتمعت مع بعض الأحبة لنقاشها. وهي ضمن سلسلة منJAMAالطبية تحتوي مقالات مختصة بالذكاء الاصطناعي وتطبيقاته الطبية: Benefits, Limits, and Risks of GPT-4 as an AI chatbot in Medicine #GPT4 #AI #Medicine https://t.co/wzQwZlMz6y
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/ZjCiBjPI7l
AI is changing healthcare in amazing ways. As doctors, let's use it wisely. The future is bright and it's coming fast. Can't wait to see what's next! #MEDTECH #NeuroTwitter #ArtificialIntelligence https://t.co/v0CHT2fOM3
RT @moorejh: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/iefPmfg479 #ICYMI #artificialintelligence #cha…
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/iImuRD5Z0w
RT @JJRiosBlanco: “If used carefully and with an appropriate degree of caution, these evolving tools have the potential to help health care…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @UICOquironsalud: Benefits, Limits, and Risks of #GPT4 as an #AI #Chatbot for #Medicine https://t.co/JtHcZunziY
Key Points: 1. Data Privacy concerns re introducing AI/LLM 2. Biases within the AI need to be evaluated 3. Potential is big within: - Medical Note Taking - 'Curb-side' consultation - Medical Exams ( USMLE/MRCPI etc) https://t.co/v8RFhQfthY https://t.co/cZ4gBohChe
En este artículo The New England analiza limitaciones, usos y riesgos de GPT-4. Considerada una herramienta extremadamente potente, pero también con limitaciones. Hoy en día el foco está en estas herramientas por su potencial y la necesidad de regularlas. https://t.co/n6lAmJZM0F
RT @JJRiosBlanco: “If used carefully and with an appropriate degree of caution, these evolving tools have the potential to help health care…
RT @JJRiosBlanco: “If used carefully and with an appropriate degree of caution, these evolving tools have the potential to help health care…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
“If used carefully and with an appropriate degree of caution, these evolving tools have the potential to help health care providers give the best care possible” Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/OyDpr12fY9
Benefits, Limits, and Risks of #GPT4 as an #AI #Chatbot for #Medicine https://t.co/JtHcZunziY
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @CALonghurst: @peteratmsr @sethHain @UCSDHealth @marlene_mmm @mtaiseale @UCSDH_IS Thanks Peter - we will certainly share with others, an…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @CALonghurst: @peteratmsr @sethHain @UCSDHealth @marlene_mmm @mtaiseale @UCSDH_IS Thanks Peter - we will certainly share with others, an…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
@peteratmsr @sethHain @UCSDHealth @marlene_mmm @mtaiseale @UCSDH_IS Thanks Peter - we will certainly share with others, and have been using your outstanding @NEJM article as a guide! https://t.co/PsBs35wuak
RT @Bob_Wachter: Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://…
Getting up to speed w/ GPT-4 & healthcare, good options featuring @microsoft research head @peteratmsr: 1) @NEJM: https://t.co/waBaFAWMwB 2) @AllenInstitute Talk: https://t.co/KNCruSbEgv 3) Book: https://t.co/HG4K2PXLR3 Non-MSFT: our @UCSF grand rounds: https://t.co/QKRbMi5mFV
@jcbriscoe1 TL;DR -- not really (see, eg https://t.co/LFOlGTbkRj)
Trending on PubMed: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. https://t.co/CnZX4mjXVz
RT @JusueMD: Must read paper about #GPT4 #AI use in clinical practice by the head of Microsoft research @peteratmsr @NEJM https://t.co/gnd…
RT @triadsou: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/zVMJjNFA96
RT @georgebest1969: NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
RT @triadsou: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/zVMJjNFA96
RT @triadsou: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/zVMJjNFA96
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/zVMJjNFA96
RT @georgebest1969: NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
https://t.co/iV3tlew2tr
RT @georgebest1969: NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
RT @georgebest1969: NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
RT @georgebest1969: NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
NEJMのChatGPT4についての特別論考と東大の太田先生の論考。両文の違いが非常に興味深い。 https://t.co/HWb6pbtkTr https://t.co/WObJ1JjH9z
RT @msharmas: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/Dv8Q5k47yb #AIinHealth
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine | NEJM https://t.co/Dv8Q5k47yb #AIinHealth
RT @JusueMD: Must read paper about #GPT4 #AI use in clinical practice by the head of Microsoft research @peteratmsr @NEJM https://t.co/gnd…
RT @JusueMD: Must read paper about #GPT4 #AI use in clinical practice by the head of Microsoft research @peteratmsr @NEJM https://t.co/gnd…
First off, I'm absolutely giddy about GPT-4's capabilities on a variety of medical tasks -- especially remarkable given that GPT-4 has no specific clinical training. Still, let's look critically at an excerpt from the supplemental appendix of https://t.co/0eVqhDH96L
Must read paper about #GPT4 #AI use in clinical practice by the head of Microsoft research @peteratmsr @NEJM https://t.co/gndUbCm2M1
RT @agingdoc1: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/gN6QdbJEu1
¿Cómo se debe evaluar la inteligencia general de una herramienta como Chat box? ¿Hasta qué punto el usuario puede “confiar” en él? ¿Cómo cambiará el desempeño de la Medicina? https://t.co/W49Urp95zN
RT @agingdoc1: Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/gN6QdbJEu1
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine https://t.co/gN6QdbJEu1
Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine. https://t.co/H1tBFHhjjC
RT @CeoImed: ｢AI医療チャットボットの可能性とリスク｣ (NEJM) 1️⃣ 医療文書作成、診断支援、研究資料要約など、多岐にわたる医療分野での活用 2️⃣ GPT-4はUSMLEの問題に対して90%以上の正答率 3️⃣ 注意点: 誤った情報を伝えることが…
RT @CeoImed: ｢AI医療チャットボットの可能性とリスク｣ (NEJM) 1️⃣ 医療文書作成、診断支援、研究資料要約など、多岐にわたる医療分野での活用 2️⃣ GPT-4はUSMLEの問題に対して90%以上の正答率 3️⃣ 注意点: 誤った情報を伝えることが…
RT @CeoImed: ｢AI医療チャットボットの可能性とリスク｣ (NEJM) 1️⃣ 医療文書作成、診断支援、研究資料要約など、多岐にわたる医療分野での活用 2️⃣ GPT-4はUSMLEの問題に対して90%以上の正答率 3️⃣ 注意点: 誤った情報を伝えることが…
｢AI医療チャットボットの可能性とリスク｣ (NEJM) 1️⃣ 医療文書作成、診断支援、研究資料要約など、多岐にわたる医療分野での活用 2️⃣ GPT-4はUSMLEの問題に対して90%以上の正答率 3️⃣ 注意点: 誤った情報を伝えることがあるため、チェックが必要 #AI #GPT4 #HealthTech https://t.co/6az5lXmCxj https://t.co/5TVQEFjBsk